Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Delhi seized ₹20 lakh in insulin from four firms over label fraud and improper storage, with two booked and samples tested.
The Delhi Drugs Control Department seized insulin worth ₹20.06 lakh from four of six inspected wholesale firms during a special enforcement drive, citing violations of the Drugs and Cosmetics Act and Drugs Rules.
Insulin products, including Tresiba, Glaritus, Humalog, Apidra, and Toujeo, were found with defaced labels suggesting government or institutional supply and lacking valid purchase records.
Two firms stored insulin at room temperature, breaching cold chain requirements.
A total of 2,104 units were confiscated, two firms were booked, and samples sent for quality testing.
Delhi Health Minister Pankaj Kumar Singh emphasized strict action against violations of regulations for life-saving drugs, reaffirming the government’s commitment to public health and drug safety.
Delhi incautó ₹ 20 lakh en insulina de cuatro firmas por fraude de etiquetas y almacenamiento inadecuado, con dos casos registrados y muestras analizadas.